Nurix Therapeutics, Inc.
Status: Publicly traded
Direct answer
Nurix Therapeutics, Inc. is publicly traded on NASDAQ under the ticker NRIX.
Nurix Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases. The company develops NX-5948, an orally bioavailable BTK degrader, that is in Phase 2 clinical trials for the treatment of relapsed or refractory B-cell malignancies and...
Can you invest in Nurix Therapeutics, Inc.?
Yes. Nurix Therapeutics, Inc. trades publicly on NASDAQ as NRIX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Nurix Therapeutics, Inc.
Detailed equity research is provided by MarketSnap.